General Psychiatry
2024
Natasha Yixuan Ong, Finn Jing Jie Teo, Jane Zi Ying Ee et al.
74 citations
Growing evidence attests to the efficacy of mindfulness-based interventions (MBIs), but their effectiveness for healthcare workers remains uncertain. To evaluate the evidence for MBIs in improving healthcare workers' psychological well-being. A systematic literature search was conducted on Medline, Embase, Cumulative Index for Nursing and Allied Health Literature, PsycINFO and Cochrane Central...
General Psychiatry
August 1, 2020
Abdullah Ramadan, I. Mansour
16 citations
Major depressive disorder (MDD) is a common, serious, debilitating condition affecting 350 million people worldwide, which remains to be unsatisfactorily treated with 53% of patients still complaining of symptoms after completing their courses with the correct dosage. Ketamine, which was approved by the Food and Drug Administration in 2019, is a potential treatment option for those recalcitrant...
General Psychiatry
July 13, 2020
Hui Shen, Meijuan Chen, Donghong Cui
43 citations
In recent years, research on meditation as an important alternative therapy has developed rapidly and been widely applied in clinical medicine. Mechanism studies of meditation have also developed progressively, showing that meditation has great impact on brain structure and function, and epigenetic and telomere regulation. In line with this, the application of meditation has gradually been...
General Psychiatry
June 18, 2020
Xiao-Mei Li, Zhan-Ming Shi, Hua Hu et al.
13 citations
Background The use of ketamine in electroconvulsive therapy (ECT) has been examined in the treatment of major depressive disorder (MDD); however, there has been no systematic review and meta-analysis of related randomised controlled trials (RCTs).Aim To examine the efficacy and safety of ketamine augmentation of ECT in MDD treatment.Methods Two reviewers searched Chinese (China National...
General Psychiatry
December 1, 2019
Eric Bui, Franklin King, Andrew Melaragno
14 citations
While limited advances have occurred in the past 30 years in the pharmacological management of anxiety and stress-related disorders, novel molecular pathways both within and without the monoamine systems are currently under investigation and offer promising new avenues for more effective future treatments. Enhancing psychotherapy approaches with pharmacological compounds offers the potential to...